CompuGroup Medical - analyst consensus and technical picture

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 19:37 CET. Details in the imprint.

CompuGroup Medical (DE000A288904) currently trades without a new ad-hoc release or major newswire report, leaving investors to focus on chart levels and existing analyst views. On this technical Thursday, the health IT provider’s stock is mainly guided by market sentiment and fundamentals already known from prior quarters.

What the chart is signaling

CompuGroup Medical shares are listed on Xetra under the ticker COP, with liquidity also on Tradegate, and form part of Germany’s TecDAX technology index. As of the latest Xetra close, the stock trades in the low EUR 30 range, broadly in the middle of its 52-week band.

Chart data from exchange and charting platforms show that CompuGroup Medical trades moderately above its recent multi-month lows but still below its highs from earlier in the year. Volatility over recent weeks has been contained compared with some higher-beta software names in the German mid-cap universe.

Thursday focus on technicals

On a Thursday technical review, traders typically watch medium-term moving averages and key support zones. For CompuGroup Medical, market data indicate that the stock is trading near its 100-day moving average, while the 200-day line remains an additional medium-term reference point for investors.

Daily turnover in CompuGroup Medical shares has recently stayed within its usual corridor for a TecDAX health IT name, without outsized volume spikes. Against this backdrop, day-to-day price changes mainly reflect broader sector sentiment and interest-rate expectations for growth stocks.

How analysts currently rate the stock

Without fresh research this week, investors look at the existing analyst consensus compiled on data platforms such as MarketScreener and finanzen.net. According to these aggregators, the analyst community remains broadly constructive on CompuGroup Medical, with a mix of Buy and Hold ratings.

Across the sampled houses, average 12-month price targets sit above the current market price, indicating upside potential from today’s levels according to these sources. The spread of individual targets reflects differing views on digitalization speed in healthcare and CompuGroup Medical’s margin trajectory.

Where earnings expectations stand

Consensus data for the current fiscal year point to single-digit organic revenue growth and a further improvement in profitability metrics, including adjusted EBITDA and earnings per share, compared with the prior year. These expectations incorporate cost-efficiency initiatives and ongoing cloud and subscription roll-out in core markets.

For the subsequent year, analysts on average model continued revenue expansion and margin gains, helped by cross-selling between software modules and higher recurring revenue share. Any deviation from these paths in the next earnings report would likely influence both the chart and rating stance.

Regulatory filings and guidance framework

CompuGroup Medical’s latest official outlook and guidance details are available in its recent financial reports and the guidance section of its investor relations website, which outlines mid-term ambitions on revenue and margins for the group’s segments. The company regularly updates investors via quarterly reports, conference calls and presentations.

In addition, mandatory disclosures under German and EU capital-market rules are published through the company’s ad-hoc and regulated information channels, providing timely updates on material events such as acquisitions, major contracts or changes in the management board.

The business behind the stock

CompuGroup Medical generates its revenue primarily from health IT solutions, ranging from practice management and information systems for doctors and hospitals to pharmacy software and e-health connectivity services. A large proportion of its business is based on recurring license, maintenance and subscription fees.

Across Europe and selected international markets, CompuGroup Medical aims to benefit from ongoing digitalization of healthcare, including electronic patient records and telemedicine. Its software platforms are designed to connect doctors, pharmacies, laboratories and payers along the treatment chain.

Where the stock trades today

The shares of CompuGroup Medical (DE000A288904) trade on Xetra at EUR 30.00 as of 06/18/2026, 17:30 CET.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.